These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37584065)

  • 1. Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
    Han E; Lee YH
    Clin Mol Hepatol; 2023 Oct; 29(4):980-983. PubMed ID: 37584065
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
    Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
    Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
    Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
    J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lean nonalcoholic fatty liver disease and sarcopenia.
    Chen M; Cao Y; Ji G; Zhang L
    Front Endocrinol (Lausanne); 2023; 14():1217249. PubMed ID: 37424859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
    Chun HS; Lee M
    Clin Mol Hepatol; 2023 Apr; 29(2):377-380. PubMed ID: 36907573
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between obese and non-obese nonalcoholic fatty liver disease.
    Chan WK
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S58-S67. PubMed ID: 36472052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.
    Chrysavgis L; Ztriva E; Protopapas A; Tziomalos K; Cholongitas E
    World J Gastroenterol; 2020 Nov; 26(42):6514-6528. PubMed ID: 33268944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease.
    Ye Q; Yan J; Xiao HJ; Han T
    Turk J Gastroenterol; 2021 Feb; 32(2):116-122. PubMed ID: 33960934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.
    Kashiwagi K; Takayama M; Fukuhara K; Shimizu-Hirota R; Chu PS; Nakamoto N; Inoue N; Iwao Y; Kanai T
    Clin Nutr ESPEN; 2020 Aug; 38():86-93. PubMed ID: 32690183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
    Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
    Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
    Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
    Polyzos SA; Vachliotis ID; Mantzoros CS
    Metabolism; 2023 Oct; 147():155676. PubMed ID: 37544590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease.
    Lai R; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2984. PubMed ID: 36842631
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
    Kim Y; Han E; Lee JS; Lee HW; Kim BK; Kim MK; Kim HS; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Lee YH; Kim SU
    Gut Liver; 2022 Mar; 16(2):290-299. PubMed ID: 34238770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity.
    Han E; Kim MK; Im SS; Jang BK; Kim HS
    J Diabetes Complications; 2022 Aug; 36(8):108253. PubMed ID: 35817677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
    Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.